Members of the wealthy Sackler family, owners of OxyContin maker Purdue Pharma LP, have long denied that the $10 billion they transferred from their company over the course of a decade was an unlawful attempt to shield assets in anticipation of litigation over their role in the opioid crisis.
Trending:
Sacklers cited fear of OxyContin lawsuits before transferring $10 billion from their company, documents show